Amanta Healthcare Share Price | Amanta Healthcare Stock Screener
AMANTA
Pharmaceuticals
Share Price NSE
₹157.14
▲
5.32 (3.50%)
Share Price BSE
₹165.05
▲
2.55 (1.57%)
As of June 15, 2026, the Amanta Healthcare share price (NSE: AMANTA) is ₹157.14 on NSE and ₹165.05 on BSE, up 3.50% from the previous close, with shares trading between ₹154.00 and ₹161.00, and a 52-week range of ₹95.03–₹157.14.
Analyse AMANTA price trends and track historical price performance.
Use the Amanta Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Amanta Healthcare Market Cap
₹625.15 Cr.
AMANTA P/E Ratio (TTM)
41.92
Amanta Healthcare P/B Ratio
2.83
EPS (TTM)
₹4.33
Dividend Yield
-
Debt to Equity
2.12
AMANTA 52 Week High
₹157.14
Amanta Healthcare 52 Week Low
₹95.03
Operating Margin
20.00%
Profit Margin
4.51%
AMANTA Revenue (TTM)
₹288.00
EBITDA
₹57.00
Net Income
₹13.00
Total Assets
₹558.00
Total Equity
₹220.00
Amanta Healthcare Share Price Chart
Screen Amanta Healthcare share price with an interactive chart. Analyse AMANTA price trends and volatility across different timeframes.
Amanta Healthcare Company Profile - Fundamental Screener
Screen Amanta Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AMANTA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE084K01015
Amanta Healthcare Balance Sheet Screener
Screen AMANTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 558 | 382 | 352 | 374 | 392 | 392 | 388 |
| Current Assets | 239 | 138 | 118 | 131 | 136 | 131 | 105 |
| Fixed Assets | 289 | 217 | 228 | 232 | 240 | 242 | 244 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 197 | 170 | 184 | 214 | 214 | 262 | 285 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 220 | 96 | 66 | 63 | 72 | 7 | 29 |
| Share Capital | 39 | 29 | 27 | 27 | 37 | 27 | 27 |
| Reserves & Surplus | 181 | 68 | 40 | 36 | 36 | -20 | 2 |
Amanta Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Amanta Healthcare income statement and profit fundamentals.
Analyze AMANTA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Amanta Healthcare share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|
| Revenue | 288 | 276 | 282 | 263 | 227 | 172 | 187 |
| Expenses | 230 | 215 | 223 | 206 | 173 | 133 | 147 |
| EBITDA | 57 | 61 | 59 | 56 | 54 | 39 | 40 |
| Operating Profit % | 20.00% | 22.00% | 21.00% | 20.00% | 23.00% | 22.00% | 20.00% |
| Depreciation | 19 | 18 | 20 | 18 | 17 | 17 | 17 |
| Interest | 21 | 28 | 34 | 35 | 49 | 40 | 38 |
| Profit Before Tax | 21 | 15 | 5 | 3 | 62 | -18 | -15 |
| Tax | 9 | 4 | 2 | 5 | 7 | 4 | 4 |
| Net Profit | 13 | 11 | 4 | -2 | 55 | -22 | -19 |
| EPS | 4.33 | 3.71 | 1.35 | -0.79 | 20.54 | -8.14 | -7.04 |
Amanta Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen AMANTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 47 | 58 | 43 | 62 | 31 | 38 |
| Investing Activities | -25 | -10 | -7 | -6 | -13 | -9 |
| Financing Activities | -24 | -46 | -42 | -50 | -18 | -37 |
| Net Cash Flow | -1 | 1 | -6 | 6 | 0 | -8 |
Amanta Healthcare Shareholding Pattern Screener
See Amanta Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check Amanta Healthcare promoter holding and ownership changes for AMANTA on TickJournal.
| Item | 2026-Mar | 2025-Feb | 2025-Jun | 2025-Aug | 2025-Sept | 2025-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|
| Promoter Holding | 63.72% | 85.52% | 63.56% | 85.60% | 63.56% | 63.56% | 85.52% |
| FII Holding | 0.85% | 0.00% | 2.21% | 0.00% | 1.00% | 1.10% | 0.00% |
| DII Holding | 12.88% | 0.00% | 12.22% | 0.00% | 11.34% | 11.24% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 16.00% | 0.00% | 20.28% | 0.00% | 17.35% | 16.91% | 0.00% |
| Other Holding | 6.56% | 14.48% | 1.74% | 14.40% | 6.75% | 7.19% | 14.48% |
| Shareholder Count | 15,222 | 200 | 30,695 | 361 | 360 | 16,181 | 192 |
Amanta Healthcare Share Dividend Screener - Share Yield Analysis
Check Amanta Healthcare dividend history with payout and yield data.
View Amanta Healthcare dividend details including ex-dates and amounts for AMANTA stock.
Amanta Healthcare Stock Index Membership
See which indices include Amanta Healthcare stock.
Check AMANTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Amanta Healthcare Market Events Screener - Corporate Actions
Get Amanta Healthcare corporate actions including splits, bonuses, and buybacks.
Check Amanta Healthcare stock events that may affect AMANTA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Quarterly Result Announcement | NA | -0.50% | ||
| 2026-05-19 | 2026-05-19 | Quarterly Result Announcement | NA | -9.66% |
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | 1.14% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -1.63% |
Amanta Healthcare Competitors Screener - Peer Comparison
Screen AMANTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 452,731 | 38.83 | 58,220 | 6.38% | 11,565 | 60.32 |
| Divis Laboratories | 175,793 | 68.00 | 10,560 | 8.73% | 2,520 | 44.73 |
| Torrent Pharmaceuticals | 157,113 | 73.17 | 13,886 | 20.34% | 2,138 | 62.27 |
| Cipla | 118,131 | 30.65 | 29,045 | 2.24% | 3,870 | 69.96 |
| Dr Reddys Laboratories | 113,131 | 27.24 | 33,593 | -0.44% | 3,998 | 66.21 |
| Zydus Life Science | 112,789 | 21.84 | 26,720 | 13.65% | 5,242 | 62.64 |
| Lupin | 111,080 | 20.66 | 27,488 | 19.98% | 5,345 | 68.05 |
| Mankind Pharma | 104,942 | 54.26 | 14,278 | 12.03% | 1,750 | 64.79 |
| Aurobindo Pharma | 90,484 | 26.13 | 33,385 | 3.21% | 3,376 | 69.05 |
| Laurus Labs | 82,312 | 92.10 | 6,868 | 22.01% | 890 | 72.35 |
Amanta Healthcare Company Announcements - News Screener
Screen AMANTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-03 | Closure of Trading Window | - |
| 2026-06-28 | Intimation Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 | - |
| 2026-06-18 | Intimation Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 | - |
| 2026-06-17 | Submission Of Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 (The Insider Trading Regulations) Open-Market Sale Of Equity Shares | - |
| 2026-05-30 | Intimation For Commissioning Of Solar Power Plant For Captive Consumption | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-29 | Statement Of Deviation Or Variation In Utilization Of Funds If Any | - |
| 2026-05-29 | Statement Of Deviation Or Variation In Utilization Of Funds If Any. | - |
| 2026-05-21 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-21 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-19 | Revision In Remuneration Of Managing Director - Recommended By Board Of Directors | - |
| 2026-05-19 | Change In Auditors | - |
| 2026-05-19 | Press Release | - |
| 2026-05-19 | Investor Presentation | - |
| 2026-05-19 | Amendment To The Code | - |
| 2026-05-19 | Financial Results For FY 2025-26 | - |
| 2026-05-19 | Board Meeting Outcome for Audited Financial Results For FY 2025-26 | - |
| 2026-05-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |